Combining Antithrombotic and Fibrinolytic Agents
نویسندگان
چکیده
منابع مشابه
Combining antithrombotic and fibrinolytic agents: can it be done?
M ore than half of ischemic stroke patients who are treated with IV recombinant tissue-type plasminogen activator (rtPA) remain disabled at 3 months. The reasons are many. The IV rtPA rate of recanalizing occluded arteries is not as high as we would like, especially for large arterial occlusions, which are opened only 30% to 40% of the time. 3–6 When rtPA does effectively lyse a thrombus, it is...
متن کاملCombining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
U p until 2015, only intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) had proven to be effective for the treatment of ischemic stroke within 4.5 hours of the onset of symptoms. Intravenous thrombolysis nonetheless has certain limitations linked to the risk of causing intracerebral hemorrhage and to an insufficient rate of cerebral arterial recanalization, particular...
متن کاملAntiplatelet, Antithrombotic, and Fibrinolytic Activities of Campomanesia xanthocarpa
In a previous work based on popular belief, Campomanesia xanthocarpa Berg., popularly known as "guavirova", showed to have a potential effect in the control of a number of conditions associated with cardiovascular diseases. The aim of the present work was to investigate the effects of C. xanthocarpa extract (CXE) on antiplatelet, antithrombotic and fibrinolytic activities in mice and in human b...
متن کاملThe Antithrombotic and Fibrinolytic Effect of Natto in Hypercholesterolemia Rats
Antithrombotic and fibrinolytic activity of natto was evaluated on platelet aggregation in vitro and in vivo. Natto showed inhibitory effects on platelet aggregation induced by adenosine 5'diphosphate (ADP) and collagen. Orally administered natto also showed fibrinolytic activity in hypercholesterolemia rats. Normal levels of natto, when administered for four weeks, shortened euglobulin clot ly...
متن کاملAntithrombotic agents in cerebral ischaemia.
The current evidence suggests that aspirin is treatment of choice when compared to anticoagulants for patients with non-cardioembolic stroke. The usefulness of combination therapy (aspirin vs. with or without warfarin) is still debated. Likewise the combination of Aspirin with clopidogrel has no added advantage (MATCH Trial). However anticoagulant therapy significantly benefits high-risk patien...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2013
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.111.000090